Cyclerion fails sickle cell test, prompting pivot to CNS disease

Cyclerion fails sickle cell test, prompting pivot to CNS disease

Cyclerion Therapeutics has stopped development of olinciguat in sickle cell disease after getting a look at data from a phase 2 trial. The setback prompted Cyclerion to switch its focus to IW-6463 and the treatment of diseases of the central nervous system.
See Original Article

How Do You Measure Profitability for a Stock Like Salesforce: Net Income or Cash Flow?

A talented CFO can make accounting adjustments for a company's balance sheet to create the impression that net income is better than it actually is.
See Original Article

Why execs at RDU's biggest carrier say business travel will come back stronger

With about half of Raleigh-Durham International Airport’s flyers traditionally made up of corporate travelers, RDU officials are eager for business customers to return to the skies. But will the rise of video conferencing make business trips moot? Ed Bastian, CEO …
See Original Article

Boparan completes of GBK acquisition

Boparan Restaurant Group (BRG) has acquired Gourmet Burger Kitchen (GBK) in a pre-pack administration deal that will save 35 of the chain’s 62-strong estate. BRG, which operates Slim Chickens, Giraffe and Ed’s Easy Diner, says the deal will save more …
See Original Article

Cottonelle Flushable Wipes recalled over bacteria concerns

Kimberly-Clark has announced a recall of its popular Cottonelle Flushable Wipes and Cottonelle GentlePlus Flushable Wipes due to concerns over possible bacteria contamination. The wipes were sold throughout the United States, Canada and the …
See Original Article

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.